Search research articles
Contact Us
Filters
Showing results (11-20 of 24) with videos related to
Page
of 3
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 26, 2023
Phase I Study of Acalabrutinib Plus Danvatirsen (AZD9150) in Relapsed/Refractory Diffuse Large B-Cell Lymphoma Including Circulating Tumor DNA Biomarker Assessment
Mark Roschewski, Manish R Patel, Patrick M Reagan, et al.
JCO Precision Oncology
|
July 12, 2021
Validation of ctDNA Quality Control Materials Through a Precompetitive Collaboration of the Foundation for the National Institutes of Health
P Mickey Williams, Thomas Forbes, Steven P Lund, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 6, 2022
Circulating Tumor DNA and Late Recurrence in High-Risk Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer
Marla Lipsyc-Sharf, Elza C de Bruin, Katheryn Santos, et al.
Clinical and Translational Science
|
December 26, 2025
Lexicon for Clonal Hematopoiesis in Liquid Biopsy
Robert Tell, Ahmet Zehir, Andrew T Anfora, et al.
JCO Precision Oncology
|
May 11, 2026
Generic Protocols for the Analytical Validation of Next-Generation Sequencing-Based Circulating Tumor DNA Assays, Version 2.0
Angela Silvestro, Jonathan Baden, Kevin Billings, et al.
Cancer Research
|
April 15, 2015
Acquired Resistance to the Mutant-Selective EGFR Inhibitor AZD9291 Is Associated with Increased Dependence on RAS Signaling in Preclinical Models
Catherine A Eberlein, Daniel Stetson, Aleksandra A Markovets, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 17, 2019
Capivasertib Plus Paclitaxel Versus Placebo Plus Paclitaxel As First-Line Therapy for Metastatic Triple-Negative Breast Cancer: The PAKT Trial
Peter Schmid, Jacinta Abraham, Stephen Chan, et al.
JCO Precision Oncology
|
May 1, 2024
Serial Postoperative Circulating Tumor DNA Assessment Has Strong Prognostic Value During Long-Term Follow-Up in Patients With Breast Cancer
Jacqueline A Shaw, Karen Page, Evie Wren, et al.
The Journal of Molecular Diagnostics : JMD
|
February 24, 2023
Contrived Materials and a Data Set for the Evaluation of Liquid Biopsy Tests: A Blood Profiling Atlas in Cancer (BLOODPAC) Community Study
Kyle M Hernandez, Kelli S Bramlett, Phaedra Agius, et al.
Genome Biology
|
June 29, 2022
Deep oncopanel sequencing reveals within block position-dependent quality degradation in FFPE processed samples
Yifan Zhang, Thomas M Blomquist, Rebecca Kusko, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 24) with videos related to
Sort By:
Page
of 3
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 26, 2023
Phase I Study of Acalabrutinib Plus Danvatirsen (AZD9150) in Relapsed/Refractory Diffuse Large B-Cell Lymphoma Including Circulating Tumor DNA Biomarker Assessment
Mark Roschewski, Manish R Patel, Patrick M Reagan, et al.
JCO Precision Oncology
|
July 12, 2021
Validation of ctDNA Quality Control Materials Through a Precompetitive Collaboration of the Foundation for the National Institutes of Health
P Mickey Williams, Thomas Forbes, Steven P Lund, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 6, 2022
Circulating Tumor DNA and Late Recurrence in High-Risk Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer
Marla Lipsyc-Sharf, Elza C de Bruin, Katheryn Santos, et al.
Clinical and Translational Science
|
December 26, 2025
Lexicon for Clonal Hematopoiesis in Liquid Biopsy
Robert Tell, Ahmet Zehir, Andrew T Anfora, et al.
JCO Precision Oncology
|
May 11, 2026
Generic Protocols for the Analytical Validation of Next-Generation Sequencing-Based Circulating Tumor DNA Assays, Version 2.0
Angela Silvestro, Jonathan Baden, Kevin Billings, et al.
Cancer Research
|
April 15, 2015
Acquired Resistance to the Mutant-Selective EGFR Inhibitor AZD9291 Is Associated with Increased Dependence on RAS Signaling in Preclinical Models
Catherine A Eberlein, Daniel Stetson, Aleksandra A Markovets, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 17, 2019
Capivasertib Plus Paclitaxel Versus Placebo Plus Paclitaxel As First-Line Therapy for Metastatic Triple-Negative Breast Cancer: The PAKT Trial
Peter Schmid, Jacinta Abraham, Stephen Chan, et al.
JCO Precision Oncology
|
May 1, 2024
Serial Postoperative Circulating Tumor DNA Assessment Has Strong Prognostic Value During Long-Term Follow-Up in Patients With Breast Cancer
Jacqueline A Shaw, Karen Page, Evie Wren, et al.
The Journal of Molecular Diagnostics : JMD
|
February 24, 2023
Contrived Materials and a Data Set for the Evaluation of Liquid Biopsy Tests: A Blood Profiling Atlas in Cancer (BLOODPAC) Community Study
Kyle M Hernandez, Kelli S Bramlett, Phaedra Agius, et al.
Genome Biology
|
June 29, 2022
Deep oncopanel sequencing reveals within block position-dependent quality degradation in FFPE processed samples
Yifan Zhang, Thomas M Blomquist, Rebecca Kusko, et al.
Page
of 3